BLUEPRINT MEDICINES CORP (BPMC)
US09627Y1091 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -128.02M | -506.98M | -557.50M | -644.10M | 313.90M | |||
| Depreciation Amortization | 13.86M | 11.66M | 11.70M | 6.50M | 6.60M | |||
| Change In Working Capital | -44.17M | -41.13M | -53.80M | -23.70M | -15.60M | |||
| Interest Paid | 69.02M | 38.47M | 9.80M | N/A | 0.00 | |||
| Taxes Paid | -60.00K | -49.00K | 6.50M | 700.00K | 800.00K | |||
| Other non cash items | -83.73M | 99.60M | 97.30M | 362.60M | 82.20M | |||
| OPERATING CASH FLOW | -242.17M | -436.85M | -502.30M | -298.70M | 387.00M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -8.36M | -16.06M | -8.90M | -3.10M | -3.20M | |||
| Other Investing Activity | 5.89M | 290.10M | -140.60M | -222.80M | -431.10M | |||
| INVESTING CASH FLOW | -2.47M | 274.04M | -149.50M | -225.90M | -434.20M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 146.37M | 97.93M | 137.80M | N/A | 0.00 | |||
| Stock Issued/Repurchased | 83.62M | 21.34M | 8.20M | 50.70M | 617.80M | |||
| Other Financing Activity | N/A | -44.00K | 415.80M | 0.00 | 0.00 | |||
| FINANCING CASH FLOW | 278.88M | 119.22M | 561.80M | 50.70M | 617.80M | |||
| Exchange Rate Effect | 917.00K | 202.00K | -200.00K | -900.00K | -300.00K | |||
| CHANGE IN CASH | 35.15M | -43.38M | -90.20M | -474.80M | 570.30M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -242.17M | -436.85M | -502.30M | -298.70M | 387.00M | |||
| Capital Expenditure | -8.36M | -16.06M | -8.90M | -3.10M | -3.20M | |||
| FREE CASH FLOW | -250.53M | -452.91M | -511.20M | -301.80M | 383.80M | |||
All data in USD